The treatment, called Yescarta, treats a type of blood cancer called aggressive B-cell non-Hodgkin lymphoma. A cancer treatment that's part of 'a big new field of medicine' just got approved The drug, named Yescarta, was developed by Israeli-founded Kite Pharma.
No comments:
Post a Comment